Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank McCormick

Showing results (1-10 of 303) with videos related to

Pageof 31
Sort By:
Cancer Cell|February 14, 2018
c-Raf in KRas Mutant Cancers: A Moving TargetFrank McCormick
Nature|March 19, 2004
Cancer: survival pathways meet their endFrank McCormick
Pigment Cell & Melanoma Research|February 5, 2010
How blocking Raf activates the MAPK pathwayFrank McCormick
Expert Opinion on Therapeutic Targets|January 7, 2015
The potential of targeting Ras proteins in lung cancerFrank McCormick
Journal of Molecular Medicine (Berlin, Germany)|March 11, 2016
K-Ras protein as a drug targetFrank McCormick
Cancer Biology & Therapy|September 26, 2003
Cancer-specific viruses and the development of ONYX-015Frank McCormick
Cancer Cell|January 18, 2020
Sticking it to KRAS: Covalent Inhibitors Enter the ClinicFrank McCormick
Biological Chemistry|April 4, 2026
The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug designFrank McCormick
Advances in Cancer Research|February 1, 2022
A brief history of RAS and the RAS InitiativeFrank McCormick
Journal of Surgical Oncology|April 12, 2011
Cancer therapy based on oncogene addictionFrank McCormick
Pageof 31

Showing results (1-10 of 303) with videos related to

Sort By:
Pageof 31
Cancer Cell|February 14, 2018
c-Raf in KRas Mutant Cancers: A Moving TargetFrank McCormick
Nature|March 19, 2004
Cancer: survival pathways meet their endFrank McCormick
Pigment Cell & Melanoma Research|February 5, 2010
How blocking Raf activates the MAPK pathwayFrank McCormick
Expert Opinion on Therapeutic Targets|January 7, 2015
The potential of targeting Ras proteins in lung cancerFrank McCormick
Journal of Molecular Medicine (Berlin, Germany)|March 11, 2016
K-Ras protein as a drug targetFrank McCormick
Cancer Biology & Therapy|September 26, 2003
Cancer-specific viruses and the development of ONYX-015Frank McCormick
Cancer Cell|January 18, 2020
Sticking it to KRAS: Covalent Inhibitors Enter the ClinicFrank McCormick
Biological Chemistry|April 4, 2026
The heart of the matter: a personal view of Fred Wittinghofer's contributions to RAS biology and drug designFrank McCormick
Advances in Cancer Research|February 1, 2022
A brief history of RAS and the RAS InitiativeFrank McCormick
Journal of Surgical Oncology|April 12, 2011
Cancer therapy based on oncogene addictionFrank McCormick
Pageof 31